Adalimumab/infliximab/methotrexateNo therapeutic response: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1887卷 / 1期

关键词：

D O I：

10.1007/s40278-022-07689-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：24 / 24

相关论文

共 50 条

[1] MethotrexateNo therapeutic response: case report
Reactions Weekly, 2021, 1882 (1) : 290 - 290
[2] Acitretin/ciclosporin/methotrexateNo therapeutic response: case report
Reactions Weekly, 2021, 1848 (1) : 19 - 19
[3] Adalimumab/azathioprine/methotrexateNo improvement: case report
Reactions Weekly, 2023, 1970 (1) : 14 - 14
[4] MethotrexateNo therapeutic response: 8 case reports
Reactions Weekly, 2021, 1868 (1) : 248 - 248
[5] Adalimumab/steroidsParapsoriasis and no therapeutic response: case report
Reactions Weekly, 2022, 1912 (1) : 20 - 20
[6] Infliximab/pembrolizumabColitis and no therapeutic response: case report
Reactions Weekly, 2022, 1930 (1) : 312 - 312
[7] MethotrexateNo response and development of drug resistance: case report
Reactions Weekly, 2021, 1871 (1) : 253 - 253
[8] Adalimumab/naproxenSAPHO syndrome and no therapeutic response: case report
Reactions Weekly, 2022, 1887 (1) : 25 - 25
[9] Infliximab/unspecified antibacterialsNo therapeutic response: case report
Reactions Weekly, 2024, 2023 (1) : 204 - 204
[10] Adalimumab/infliximab/mesalazineLack of efficacy: case report
Reactions Weekly, 2023, 1981 (1) : 18 - 18

← 1 2 3 4 5 →